Research summary
A two-period review of CVX revenue, profitability and cash conversion; reported revenue growth was -4.64%.
Period comparison
FY2025 ended 2025-12-31; the prior observation ended 2024-12-31. Revenue moved from USD 193.414 billion to USD 184.432 billion. These are annual periods, not quarterly earnings or trailing-twelve-month estimates.
Earnings bridge
Net income moved from USD 17.661 billion to USD 12.299 billion. Operating income moved from not available to not available. Net margin moved from 9.13% to 6.67%. A margin change identifies an outcome; its causes require management discussion and footnotes.
Cash-flow cross-check
Operating cash flow was USD 31.492 billion in the earlier period and USD 33.939 billion in the later period. Selected free cash flow was not available and not available, respectively. Working-capital timing can cause earnings and cash to diverge.
Interpretation and limits
A rise in reported revenue does not by itself identify organic growth. A difference in EPS can reflect share-count changes as well as operating performance. No causal claim is made from these aggregate figures.
Valuation context
An earnings comparison provides a historical denominator, not a price target. A dated market price is deliberately absent from this static release.
What to monitor
Realized prices, production volumes, refining economics and capital expenditure.
Risks and uncertainties
Commodity cycles, project execution, reserve replacement, environmental liabilities and geopolitical exposure.
Sources & dates
- SEC annual filing · 2025-12-31 ↗Source date 2026-02-24
- SEC annual filing · 2024-12-31 ↗Source date 2026-02-24
- SEC annual filing · 2023-12-31 ↗Source date 2026-02-24
- SEC annual filing · 2022-12-31 ↗Source date 2025-02-21
- SEC issuer record ↗Source date 2026-09-18